Identification of biomarkers for Mycobacterium tuberculosis infection and disease in BCG-vaccinated young children in Southern India

Genes and Immunity

Volumn 14, Issue 6, 2013, Pages 356-364

  Dhanasekaran, S ^a   Jenum, S ^b   Stavrum, R ^a   Ritz, C ^c   Faurholt Jepsen, D ^c   Kenneth, J ^d   Vaz, M ^d   Grewal, H M S ^a,e   Doherty, T M ^a,f  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f GLAXOSMITHKLINE   (Denmark)

Author keywords

Bio plex assay; biomarkers; cytokines chemokines; dcRT MLPA; TB disease; TB infection

Indexed keywords

BCG VACCINE; BIOLOGICAL MARKER; CD4 ANTIGEN; CYTOKINE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CHILD; DOWN REGULATION; FEMALE; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; INDIA; INFANT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; TUBERCULOSIS; UPREGULATION;

MYCOBACTERIUM TUBERCULOSIS;

ANTIGENS, CD4; BCG VACCINE; BIOLOGICAL MARKERS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INDIA; INFANT; INFANT, NEWBORN; INTERLEUKIN-13; INTERLEUKIN-2; MALE; RAB GTP-BINDING PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; TUBERCULOSIS;

EID: 84883872226     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.26     Document Type: Article

References (52)

1. WHO. Global Tuberculosis Report 2012.
2. Delespesse G, Yang LP, Ohshima Y, Demeure C, Shu U, Byun DG et al. Maturation of human neonatal CD4\+ and CD8\+ T lymphocytes into Th1/Th2 effectors. Vaccine 1998; 16: 1415-1419. (Pubitemid 28364677)
3. Upham JW, Lee PT, Holt BJ, Heaton T, Prescott SL, Sharp MJ et al. Development of interleukin-12-producing capacity throughout childhood. Infect Immunity 2002; 70: 6583-6588. (Pubitemid 35387884)
4. Upham JW, Rate A, Rowe J, Kusel M, Sly PD, Holt PG. Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory. Infect Immunity 2006; 74: 1106-1112. (Pubitemid 43185548)
5. Seth V, Singhal PK, Semwal OP, Kabra SK, Jain Y. Childhood tuberculosis in a referral centre: clinical profile and risk factors. Indian Pediatr 1993; 30: 479-485.
6. Beyers N, Gie RP, Schaaf HS, Van Zyl S, Talent JM, Nel ED et al. A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis. Int J Tuberc Lung Dis 1997; 1: 38-43. (Pubitemid 127509684)
7. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Enarson DA, Beyers N. The spectrum of disease in children treated for tuberculosis in a highly endemic area. Int J Tuberc Lung Dis 2006; 10: 732-738. (Pubitemid 44031385)
8. Shingadia D, Novelli V. Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis 2003; 3: 624-632. (Pubitemid 37210226)
9. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011; 30: 694-700.
10. WHO. Strategic and technical advisory group for tuberculosis (STAG-TB). Report of the Tenth Meeting 2010.
11. WHO. Joint TDR/EC expert consultation on biomarkers in tuberculosis 2008.
12. Lopez Avalos GG, Prado Montes de Oca E. Classic and new diagnostic approaches to childhood tuberculosis. J Tropical Med 2012; 2012: 818219.
13. Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PloS One 2008; 3: e3901.
14. Kumar NP, Anuradha R, Suresh R, Ganesh R, Shankar J, Kumaraswami V et al. Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children. Clin Vaccine Immunol 2011; 18: 1856-1864.
15. Thomas T, Brighenti S, Andersson J, Sack D, Raqib R. A new potential biomarker for childhood tuberculosis. Thorax 2011; 66: 727-729.
16. Joosten SA, Goeman JJ, Sutherland JS, Opmeer L, de Boer KG, Jacobsen M et al. Identification of biomarkers for tuberculosis disease using a novel dual-color RTMLPA assay. Genes Immunity 2012; 13: 71-82.
17. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8: 636-647. (Pubitemid 38625076)
18. Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis 2010; 50(Suppl 3): S184-S194.
19. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010; 375: 1920-1937.
20. Schimmoller F, Simon I, Pfeffer SR. Rab GTPases, directors of vesicle docking. J Biol Chem 1998; 273: 22161-22164. (Pubitemid 28399766)
21. Brumell JH, Scidmore MA. Manipulation of rab GTPase function by intracellular bacterial pathogens. Microbiol Mol Biol Rev 2007; 71: 636-652. (Pubitemid 350309181)
22. Doherty M, Wallis RS, Zumla A. Biomarkers for tuberculosis disease status and diagnosis. Curr Opin Pulm Med 2009; 15: 181-187.
23. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, Fok AK et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994; 263: 678-681.
24. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ et al. Ras-associated small GTPase 33A, a novel T cell factor, is down-regulated in patients with tuberculosis. J Infect Dis 2005; 192: 1211-1218. (Pubitemid 41368421)
25. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Molecular Med 2007; 85: 613-621. (Pubitemid 46876510)
26. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 2011; 12: 15-22.
27. Hori S, Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect 2004; 6: 745-751. (Pubitemid 38781186)
28. Johanns TM, Ertelt JM, Rowe JH, Way SS. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 2010; 6: e1001043.
29. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006; 173: 803-810.
30. Wu B, Huang C, Kato-Maeda M, Hopewell PC, Daley CL, Krensky AM et al. Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease. J Immunol 2007; 178: 3688-3694. (Pubitemid 46417636)
31. He XY, Xiao L, Chen HB, Hao J, Li J, Wang YJ et al. T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients. Eur J Clin Microbiol Infect Dis 2010; 29: 643-650.
32. Burl S, Hill PC, Jeffries DJ, Holland MJ, Fox A, Lugos MD et al. FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol 2007; 149: 117-122. (Pubitemid 46897109)
33. Roberts T, Beyers N, Aguirre A, Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factorbeta, and interleukin-4 mRNA levels. J Infect Dis 2007; 195: 870-878. (Pubitemid 46363933)
34. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGFbeta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. Journal of immunology 1995; 154: 465-473.
35. Olmos S, Stukes S, Ernst JD. Ectopic activation of Mycobacterium tuberculosisspecific CD4\+ T cells in lungs of CCR7-/-mice. J Immunol 2010; 184: 895-901.
36. Bankaitis VA, Malehorn DE, Emr SD, Greene R. The Saccharomyces cerevisiae SEC14 gene encodes a cytosolic factor that is required for transport of secretory proteins from the yeast Golgi complex. J Cell Biol 1989; 108: 1271-1281. (Pubitemid 19097036)
37. Juffermans NP, Verbon A, van Deventer SJ, Buurman WA, van Deutekom H, Speelman P et al. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis 1998; 178: 1839-1842. (Pubitemid 28558167)
38. Vishwanath V, Meera R, Puvanakrishnan R, Narayanan PR. Fate of Mycobacterium tuberculosis inside rat peritoneal macrophages in vitro. Mol Cell Biochem 1997; 175: 169-175. (Pubitemid 27453351)
39. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 2007; 9: 806-812. (Pubitemid 46901043)
40. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Eugen-Olsen J, Ravn P. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res Notes 2009; 2: 19.
41. Frahm M, Goswami ND, Owzar K, Hecker E, Mosher A, Cadogan E et al. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis 2011; 91: 250-256.
42. Kim SY, Park MS, Kim YS, Kim SK, Chang J, Lee HJ et al. The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals, and controls with the TB antigens ESAT-6, CFP-10, and TB7.7. Scand J Immunol 2012; 76: 580-586.
43. Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr 1997; 66: 460S-463S. (Pubitemid 27360349)
44. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T et al. An interferoninducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010; 466: 973-977.
45. Mengatto L, Chiani Y, Imaz MS. Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 2006; 101: 535-542. (Pubitemid 44285796)
46. Mathur HC, Saxena S, Bhardwaj RM. Evaluation of Kenneth Jones' criteria for diagnosis of childhood tuberculosis. Indian J Pediatr 1974; 41: 349-355.
47. Hussain R, Kaleem A, Shahid F, Dojki M, Jamil B, Mehmood H et al. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Met 2002; 264: 95-108. (Pubitemid 34615896)
48. Pokkali S, Das SD. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis. Hum Immunol 2009; 70: 110-115.
49. Goeman JJ, Van De Geer SA, Van Houwelingen HC. Testing against a high dimensional alternative. J R Stat Soc B 2006; 68: 477-493. (Pubitemid 43742901)
50. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning. 2nd Edn-Springer, 2009 68-78
51. Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004; 20: 93-99. (Pubitemid 38088346)
52. Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Software 2010; 33: 1-22.